Search results for "Ande"

showing 10 items of 5018 documents

Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression

2021

Coronavirus disease 2019 (COVID-19) rapidly spread from China as a pandemic, with Italy one of the most affected countries worldwide. Unlike adults, children have a milder presentation of COVID-19, even when affected by CKD or on immunosuppressive therapy for glomerulopathies and kidney

2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Epidemiologymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibodies ViralCritical Care and Intensive Care MedicineIdiopathic Nephrotic SyndromeImmunoglobulin GPandemicPrevalenceResearch LetterHumansMedicineRenal Insufficiency ChronicChildImmunosuppression TherapyTransplantationbiologySARS-CoV-2business.industryCOVID-19InfantImmunosuppressionNephrologyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusinessClinical Journal of the American Society of Nephrology
researchProduct

Exposing Empirical Links between COVID-19 Situation Report and Available Data: The Case of Nigeria

2020

Ever since the index case of COVID-19 was announced in Nigeria, the number of confirmed cases has gradually increased to 46,140 (about 4.5% of total confirmed cases in Africa) as the time of writing this article. This seemingly low number of confirmed cases has provoked heated debates among researchers. This cross-sectional study explores the Nigerian COVID-19 report to expose some links between the number of confirmed cases, testing, and some environmental conditions. The findings reveal that there is no state in Nigeria which has up to 12 confirmed cases per 10,000 population. That means, the number of confirmed COVID-19 cases is less than 0.15% of the population of people across each sta…

2019-20 coronavirus outbreakAfrican most populous nationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Populationlcsh:MedicineNigeria010501 environmental sciences01 natural sciencesArticle03 medical and health sciences0302 clinical medicineenvironmental factors030212 general & internal medicineeducationIndex case0105 earth and related environmental scienceseducation.field_of_studypandemiclcsh:Rcorrelational studyCOVID-19low number of testingVDP::Matematikk og Naturvitenskap: 400::Matematikk: 410GeographyCorrelational studyDemographyDiseases
researchProduct

In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme I…

2020

2019-20 coronavirus outbreakAngiotensinsCoronavirus disease 2019 (COVID-19)Pneumonia ViralAngiotensin-Converting EnzymeACE2InflammationAngiotensin-Converting Enzyme InhibitorsPharmacologyArticleAngiotensin Receptor AntagonistsBetacoronavirusRenin–angiotensin systemmedicineHumansPandemicsAntihypertensive AgentsInflammationAngiotensin Receptor Antagonistsbiologybusiness.industrySARS-CoV-2COVID-19Angiotensin-converting enzymeGeneral MedicineCoronavirusAngiotensin-converting enzyme 2biology.proteinAngiotensin Receptor BlockersAngiotensin-Converting Enzyme COVID-19 coronavirus ACE2medicine.symptombusinessCoronavirus InfectionsCoronavirus InfectionsMayo Clinic proceedings
researchProduct

An expression of concern on research during the Covid-19 pandemic

2020

2019-20 coronavirus outbreakBiomedical ResearchCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralScientific MisconductSettore MED/11BetacoronavirusRetraction of Publication as TopicPandemicHumansMedicinePandemicsClinical Trials as TopicbiologySARS-CoV-2business.industryCOVID-19Reproducibility of ResultsGeneral Medicinebiology.organism_classificationVirologyCoronavirus InfectionsCardiology and Cardiovascular MedicinebusinessBetacoronavirusCoronavirus Infections
researchProduct

Towards a European strategy to address the COVID-19 pandemic

2021

2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical DistancingMass Vaccination03 medical and health sciences0302 clinical medicinePolitical scienceCorrespondencePandemicHumans030212 general & internal medicinePandemicsHealth policy030304 developmental biology0303 health sciencesSARS-CoV-2Health PolicyIncidenceIncidence (epidemiology)COVID-19General MedicineVirology3. Good healthEuropeMass vaccinationHuman medicineThe Lancet
researchProduct

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

2022

International audience; Safe and effective vaccines against coronavirus disease 2019 (COVID-19) are essential for ending the ongoing pandemic. Although impressive progress has been made with several COVID-19 vaccines already approved, it is clear that those developed so far cannot meet the global vaccine demand alone. We describe a COVID-19 vaccine based on a replication-defective gorilla adenovirus expressing the stabilized prefusion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein named GRAd-COV2. We assessed the safety and immunogenicity of a single-dose regimen of this vaccine in healthy younger and older adults to select the appropriate dose for each age group…

2019-20 coronavirus outbreakCOVID-19 VaccinesSettore BIO/06Coronavirus disease 2019 (COVID-19)COVID-19 VaccineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GorillaAdenoviridaeAdenovirus Vaccinesbiology.animalPandemicAnimalsHumansMedicineMESH: COVID-19MESH: AnimalsMESH: SARS-CoV-2AgedMESH: Adenovirus VaccinesMESH: AgedGorilla gorilla[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyMESH: HumansbiologyAnimalSARS-CoV-2business.industryMESH: Gorilla gorillaCOVID-19MESH: AdenoviridaeGeneral MedicineVirologyAdenovirus VaccineMESH: COVID-19 Vaccinesbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyHuman
researchProduct

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN…

2020

Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely…

2019-20 coronavirus outbreakCancer ResearchPneumonia ViralDiseasesSevere Acute Respiratory Syndromemedicine.disease_causeBetacoronavirusMyeloproliferative DisordersNeoplasmsSurveys and QuestionnairesPandemicmedicineHumansPandemicsCoronavirusPhiladelphia negativeMyeloproliferative DisordersbiologySARS-CoV-2business.industryHealth careCOVID-19Hematologymedicine.diseasebiology.organism_classificationVirologyCoronavirusPneumoniaItalyOncologyPerspectiveCoronavirus InfectionsbusinessCoronavirus InfectionsBetacoronavirusBetacoronavirus COVID-19 Humans Italy SARS-CoV-2 Surveys and Questionnaires Coronavirus Coronavirus Infections Myeloproliferative Disorders Neoplasms Pandemics Pneumonia Viral Severe Acute Respiratory Syndrome
researchProduct

Effects of the coronavirus disease 2019 pandemic on the number of hospitalizations for myocardial infarction: regional differences. Population analys…

2020

2019-20 coronavirus outbreakCardiac CatheterizationCoronavirus disease 2019 (COVID-19)PopulationPneumonia ViralMyocardial InfarctionBetacoronavirusPandemicmedicineHumansMyocardial infarctionCoronary Artery BypasseducationPandemicseducation.field_of_studybiologybusiness.industrySARS-CoV-2COVID-19Length of Staybiology.organism_classificationmedicine.diseaseHospitalizationPneumoniaCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsBetacoronavirusRegional differencesDemographyKardiologia Polska
researchProduct

COVID-19 and economy.

2020

2019-20 coronavirus outbreakChinaLetterCoronavirus disease 2019 (COVID-19)business.industryViral EpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINECOVID-19DermatologyGeneral Medicinemedicine.diseaseGlobal HealthVirologyPneumoniaMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning

2021

More than a year and a half after the first clinical manifestations of coronavirus disease 2019 (COVID-19) were reported in Wuhan, China,1 , 2 the magnitude of the pandemic across the globe and its related clinical and social effects3 remain unclear.4 The pandemic has affected lives and sparked concerns about everything from health to job security. In high–Gross Domestic Product (GDP) countries, despite trillions in coronavirus aid released by governments, many families still struggle to pay for basic necessities like food and rent, and these difficulties worsened during the pandemic.5 , 6 The general social uncertainty caused by the pandemic seems to have also affected family resilience, w…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Adolescentbusiness.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Family functioningMEDLINECOVID-19VirologyAdolescent ; Child ; COVID-19 ; Family ; Humans ; Pandemics ; Parent-Child Relations ; Psychosocial Functioning ; SARS-CoV-2ArticlePsychosocial FunctioningPediatrics Perinatology and Child HealthMedicineHumansFamilyParent-Child RelationsbusinessChildPandemics
researchProduct